Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 04, 2024

BUY
$114.26 - $136.0 $486,062 - $578,544
4,254 New
4,254 $523,000
Q3 2021

Oct 12, 2021

SELL
$128.64 - $184.79 $566,144 - $813,260
-4,401 Closed
0 $0
Q2 2021

Jul 30, 2021

SELL
$160.2 - $186.42 $51,103 - $59,467
-319 Reduced 6.76%
4,401 $796,000
Q1 2021

Apr 06, 2021

BUY
$150.19 - $173.5 $708,896 - $818,920
4,720 New
4,720 $794,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Fcf Advisors LLC Portfolio

Follow Fcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.